The Main Pharmaceutical Inspectorate is withdrawing from the market a series of the popular painkiller Alka-Prim. It is intended for use in the case of muscle and headaches, colds or flu.
GIF decided to withdraw a medicinal product from the market Alka-Prim, effervescent tablets 330 mg, 10 tablets, batch number: 20317 and expiry date: March 31.03.2019, XNUMX.
The entity responsible is Polpharma SA
The decision was made immediately enforceable.
The reason for the decision was distortion of the immediate packaging due to the internal reaction of the excipient with the water contained in the product.
Alka-Prim contains acetylsalicylic acid, which has analgesic, anti-inflammatory and antipyretic properties. This non-steroidal over-the-counter medication is used for mild to moderate pain. It soothes headaches, pain in muscles and teeth, its action also works in the case of high fever, viral infections and other diseases. It is in the form of effervescent tablets.